Pembrolizumab-Associated Nerve Epidermal Growth Factor-Like 1 Membranous Nephropathy
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
NELL1 membranous nephropathy: clinical associations provide mechanistic clues.
Andeen N, Kung V, Avasare R Front Nephrol. 2024; 4:1323432.
PMID: 38596642 PMC: 11002321. DOI: 10.3389/fneph.2024.1323432.
References
1.
Row P, Cameron J, Turner D, Evans D, White R, Ogg C
. Membranous nephropathy. Long-term follow-up and association with neoplasia. Q J Med. 1975; 44(174):207-39.
View
2.
Kitchlu A, Jhaveri K, Wadhwani S, Deshpande P, Harel Z, Kishibe T
. A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease. Kidney Int Rep. 2021; 6(1):66-77.
PMC: 7783581.
DOI: 10.1016/j.ekir.2020.10.002.
View
3.
Hogan J, Markowitz G, Radhakrishnan J
. Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol. 2015; 10(7):1300-10.
PMC: 4491282.
DOI: 10.2215/CJN.01910215.
View
4.
Cortazar F, Kibbelaar Z, Glezerman I, Abudayyeh A, Mamlouk O, Motwani S
. Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study. J Am Soc Nephrol. 2020; 31(2):435-446.
PMC: 7003302.
DOI: 10.1681/ASN.2019070676.
View
5.
Rihova Z, Honsova E, Merta M, Jancova E, Rysava R, Reiterova J
. Secondary membranous nephropathy--one center experience. Ren Fail. 2005; 27(4):397-402.
View